emed Partners Up With IMG To Offer Telehealth Proctored COVID-19...

emed Partners Up With IMG To Offer Telehealth Proctored COVID-19 Tests To International Travelers

Healthcare Tech Outlook | Wednesday, July 27, 2022

Customers of the IMG group can now order the number of tests they require, and eMed will deliver the tests to their address.

FREMONT, CA: eMed, one of the pioneers of the first virtually guided, quick at-home COVID-19 approved test technology and platform, has partnered up with International Medical Group® (IMG®), a multi-award-winning insurance benefits provider and help services. IMG is thrilled to make eMed's at-home COVID-19 testing available in bulk to IMG group clients going abroad. An eMed Telemedicine Proctor who supervises sample collection and the testing procedure and certifies the results oversees each test while self-administered during a telehealth session.

Upon completion of the test, the user receives an email with their certified digital lab report and, if their test result is negative, a digital health pass to an app on their smart device. With eMed's Test-to-TreatTM services, people who receive a positive test result can meet with a physician via telehealth to possibly receive treatment, such as a prescription, all for the same cost.

"We are pleased to partner with eMed to offer our groups a simple and convenient way of testing for COVID-19 prior to their travels. Since 1990, we've provided our groups with industry-leading medical benefits and services, and this is just one more way that we can be there for them while they are away from home." says Amanda Winkle, IMG Chief Commercial Officer.

"We have provided tens of millions of virtually proctored at-home COVID-19 tests to consumers, businesses, and governments, and we are excited to provide this testing solution to IMG customers who are traveling abroad. With test results available in 15 minutes, we are proud to offer customers a convenient, reliable COVID-19 testing option they can trust without the hassle of having to find testing in a foreign country." says Dr. Patrice Harris, Co-Founder, and CEO of eMed.

Weekly Brief